MétaCan
Menu
Back to cohort
Record W3135366498

Functional requirement for RGD and PKD domains of GPNMB in breast cancer metastasis

2008· article· en· W3135366498 on OpenAlexaff
April A. N. Rose, Caterina Russo, Matthew G. Annis, Peter M. Siegel

Bibliographic record

VenueCancer Research · 2008
Typearticle
Languageen
FieldMedicine
TopicPeptidase Inhibition and Analysis
Canadian institutionsMcGill University
Fundersnot available
KeywordsBreast cancerMetastasisMedicineEctopic expressionCancer researchCancerCA15-3MelanomaCA 15-3Metastatic breast cancerOncologyCancer cellLung cancerInternal medicineBiologyCell culture
DOInot available

Abstract

fetched live from OpenAlex

3681 The morbidity and mortality associated with breast cancer results primarily from the spread of cancer cells from the breast to secondary organs. Currently, there are very few available therapies that effectively target breast cancer metastases. Identification and characterization of the functional mediators of metastasis is critical to the development of targeted anti-metastatic therapies.
 We have recently identified GPNMB (Osteoactivin, DC-HIL, HGFIN) as a novel mediator of breast cancer metastasis to bone. Here, we show the GPNMB protein is detectable in a subset of human breast cancer cell lines, but undetectable in normal breast epithelial cells. Furthermore, GPNMB is highly expressed in in vivo selected, aggressively lung-metastatic breast cancer cells, and ectopic expression of this gene in 66cl4 mammary carcinoma cells is sufficient to promote primary tumor growth and spontaneous lung metastases in vivo. These results argue that GPNMB may function as a more general regulator of breast cancer metastasis. To further investigate the relevance of GPNMB expression in human breast cancer, we have analyzed the gene expression profiles from 3 independent datasets comprising 99, 118, and 295 human breast tumors. Kaplan-Meier analysis reveals significant correlations in each dataset, between increased GPNMB expression and shorter metastasis-free and overall survival times.
 An increasing body of literature is emerging, linking high levels of GPNMB expression with progression of diverse cancer types. Indeed, a GPNMB-targeted, cytotoxin conjugated antibody (CR011 vc-MMAE) is currently being investigated in Phase I clinical trials as a therapy for patients with Stage III/IV melanoma. Despite these observations, very little known about the metastasis-promoting functions of this protein. To further our understanding of GPNMB-dependent pro-metastatic effects, we have generated mutations that disrupt specific domains within the protein. GPNMB is a type I transmembrane glycoprotein with an extracellular integrin recognition motif (RGD), a putative ligand binding domain (PKD), a single transmembrane domain and a short cytoplasmic tail. Our data show that GPNMB enhances the invasive capacity of breast cancer cells in a PKD-dependent manner and promotes adhesion to endothelium in an RGD dependent manner. Due to its role in promoting endothelial adhesion and invasion, we are currently developing a model to monitor GPNMB-dependent extravasation of breast cancer cells in vivo.
 Together, these results offer mechanistic insight into the metastogenic roles of GPNMB, a molecule that is highly expressed in aggressive human breast cancers. Moreover, this data provides further rationale toward the pursuit of GPNMB-targeted therapies for breast cancer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.557
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.189
GPT teacher head0.443
Teacher spread0.254 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2008
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicPeptidase Inhibition and AnalysisFrench-language works237,207